NewEdge Advisors, LLC

Position in INCY — Incyte Corp

CIK 1633516 NEW ORLEANS, LA

Position in INCY

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$3,922,822

+$2,001,269 QoQ

Shares Held

34,605

+69.5% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#259

of 854 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 15% Shared 0% None 85%

Healthcare · as of Jun 30, 2026

NewEdge Advisors, LLC holds $47,755,733 across 102 Biotechnology names. INCY ranks #4 (8.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	18,435	$9,157,217
2	REGN	Regeneron Pharmaceuticals, Inc.	11,911	$7,426,984
3	NUVB	Nuvation Bio Inc.	1,231,733	$6,996,243
4	INCY	Incyte Corp This page	34,605	$3,922,822
5	PHAT	Phathom Pharmaceuticals, Inc.	203,962	$2,212,987
6	EXEL	Exelixis, Inc.	32,532	$1,770,066
7	BMRN	Biomarin Pharmaceutical Inc	27,287	$1,561,362
8	RPRX	Royalty Pharma plc	21,597	$1,210,943

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,922,822	34,605	+69.5%	Shares	Sole	2026-08-12
2026-03-31	$1,921,553	20,416	+55.6%	Shares	Sole	2026-06-03
2025-12-31	$1,296,257	13,124	+21.2%	Shares	Sole	2026-02-18
2025-09-30	$918,068	10,825	+9.3%	Shares	Sole	2025-11-17
2025-06-30	$674,598	9,906	-21.4%	Shares	Sole	2025-08-14
2025-03-31	$762,748	12,597	+369.3%	Shares	Sole	2025-05-15
2024-12-31	$185,383	2,684	-61.5%	Shares	Sole	2025-02-13
2024-09-30	$460,849	6,972	-69.8%	Shares	Sole	2024-11-14
2024-06-30	$1,399,533	23,087	+23.9%	Shares	Sole	2024-08-16
2024-03-31	$1,061,408	18,631	+18719.2%	Shares	Sole	2024-05-14
2023-12-31	$6,216	99	-98.8%	Shares	Sole	2024-02-13
2022-12-31	$670,912	8,353	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.